RE: Uk govt press release part 24 Apr 2020 14:22
Our wholly-owned drug, SNG001, has already been well tolerated in clinical trials in more than 200 respiratory patients to date and has accelerated lung function recovery in two Phase II asthma trials in patients with a cold or flu infection.
Fingers crossed for all in need